5FU and Oxa paper by medivizor

Please feel free to read, share your thoughts, your stories and connect with others!
User avatar
beach sunrise
Posts: 1033
Joined: Thu Mar 05, 2020 7:14 pm

5FU and Oxa paper by medivizor

Postby beach sunrise » Tue Sep 21, 2021 1:42 pm

8/19 RC CEA 82.6 T3N0M0
5FU/rad 6 wk
IVC 75g 1 1/2 wks before surgery. Continue 2x a week
Surg 1/20 -margins T4bN1a IIIC G2 MSI- 1/20 LN+ LVI+ PNI-
pre cea 24 post 5.9
FOLFOX
7 rds 6-10 CEA 11.4 No more
CEA
7/20 11.1 8.8
8/20 7.8
9/20 8.8, 9, 8.6
10/20 8.1
11/20 8s
12/20 8s-9s
ADAPT++++ chrono
CEA
10/23/22 26.x
12/23/22 22.x
2023
1/5 17.1
1/20 15.9
3/30 14.9
6/12 13.3
8/1 2.1
Nodule RML SUV 1.3 5mm
Rolles 3 of 4 lung nodules cancer
KRAS
Chem-sens test failed Not enough ca cells to test

Rock_Robster
Posts: 1027
Joined: Thu Oct 25, 2018 5:27 am
Location: Brisbane, Australia

Re: 5FU and Oxa paper by medivizor

Postby Rock_Robster » Wed Sep 22, 2021 9:07 am

Very interesting - thanks for sharing this. I’d tend to be careful with interpreting these, as it wasn’t a randomised controlled trial. The allocation of patients into the groups wasn’t done randomly, but instead based on clinical treatment decisions made by the oncologists at the time, which is highly likely to be confounded by a number of other factors (eg generally healthier/younger/stronger patients are more likely to be given oxaliplatin, compared to older patients or those with multiple comorbidities). Or conversely doctors may be more likely to prescribe oxy where they think a patient is at greater risk of recurrence/progression, partially explaining why oxaliplatin patients overall didn’t appear to do better.

While they’ve attempted to correct for this in the statistical analysis, unfortunately this type of trial still struggles to show more than correlation (ie I would be very hesitant to withhold oxaliplatin from any particular stage III patient without multiple RCTs. The difficulty here could be ethics, if FOLFOX is accepted as standard of care).
41M Australia
2018 Dx RC
G2 EMVI LVI, 4 liver mets
pT3N1aM1a Stage IVa MSS NRAS G13R
CEA 14>2>32>16>19>30>140>70
11/18 FOLFOX
3/19 Liver resection
5/19 Pelvic IMRT
7/19 ULAR
8/19 Liver met
8/19 FOLFOX, FOLFOXIRI, FOLFIRI
12/19 Liver resection
NED 2 years
11/21 Liver met, PALN, lung nodules
3/22 PVE, lymphadenectomy, liver SBRT
10/22 PALN SBRT
11/22 Liver mets, peri nodule. Xeloda+Bev
4/23 XELIRI+Bev
9/23 ATRIUM trial
12/23 Modified FOLFIRI+Bev
3/24 VAXINIA (CF33 + hNIS) trial

User avatar
beach sunrise
Posts: 1033
Joined: Thu Mar 05, 2020 7:14 pm

Re: 5FU and Oxa paper by medivizor

Postby beach sunrise » Wed Sep 22, 2021 12:11 pm

Agreed. My thought about the paper was over 60 yrs old they really just don't know if it will help or just poison the person. There were a few questions about the sudy. Medivizor is good to read though.
AND, Oxa only poisoned me, did not phase cancer cells. So, I didn't get the 3-5% gain it supposedly declares.
8/19 RC CEA 82.6 T3N0M0
5FU/rad 6 wk
IVC 75g 1 1/2 wks before surgery. Continue 2x a week
Surg 1/20 -margins T4bN1a IIIC G2 MSI- 1/20 LN+ LVI+ PNI-
pre cea 24 post 5.9
FOLFOX
7 rds 6-10 CEA 11.4 No more
CEA
7/20 11.1 8.8
8/20 7.8
9/20 8.8, 9, 8.6
10/20 8.1
11/20 8s
12/20 8s-9s
ADAPT++++ chrono
CEA
10/23/22 26.x
12/23/22 22.x
2023
1/5 17.1
1/20 15.9
3/30 14.9
6/12 13.3
8/1 2.1
Nodule RML SUV 1.3 5mm
Rolles 3 of 4 lung nodules cancer
KRAS
Chem-sens test failed Not enough ca cells to test


Return to “Colon Talk - Colon cancer (colorectal cancer) support forum”



Who is online

Users browsing this forum: Google [Bot], Thomasnug and 114 guests